Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney

International Journal of Toxicology

Volumn 30, Issue 5, 2011, Pages 510-517

  Rjiba Touati, Karima ^a   Boussema, Imen Ayed ^a   Belarbia, Anis ^b   Achour, Abdelatif ^b   Bacha, Hassen ^a  

^a Faculty of Dentistry   (Tunisia)

^b University Hospital of Sahloul   (Tunisia)

Author keywords

antioxidant property; cisplatin; nephroprotection; recombinant human erythropoietin

Indexed keywords

CISPLATIN; CREATININE; GLUTATHIONE; MALONALDEHYDE; RECOMBINANT ERYTHROPOIETIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; KIDNEY FAILURE; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; SINGLE DRUG DOSE; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BLOOD UREA NITROGEN; CATALASE; CISPLATIN; CREATININE; ERYTHROPOIETIN; GLUTATHIONE; HUMANS; KIDNEY; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

RATTUS;

EID: 80054809746     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581810411931     Document Type: Conference Paper

References (44)

1. Mishima K, Baba A, Matsuo M, Itoh Y, Oishi R. Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radic Biol Med. 2006 ; 40 (9). 1564-1577
2. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003 ; 23 (5). 460-464 (Pubitemid 37176691)
3. Taguchi T, Nazneen A, Abid MR, Razzaque MS. Cisplatin associated nephrotoxicity and pathological events. Contrib Nephrol. 2005 ; 148: 107-121 (Pubitemid 43264925)
4. Schnellmann RG The Basic Science of Poisons. Klaassen CD, ed. New York, NY: Casarett, Doulls Toxicology, McGraw-Hill ; 2001: 491-514.
5. Hanigan MH, Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 2003 ; 1: 47-61
6. Al-Majed AA. Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rat. Basic Clin Pharmacol Toxicol. 2007 ; 100 (3). 145-150
7. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev. 1999 ; 31 (4). 971-997
8. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000 ; 109 (8). 665-678
9. Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med. 2003 ; 142 (3). 178-186 (Pubitemid 37260471)
10. Antunes LMG, Darin JDC, Bianchi MLP. Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res. 2001 ; 43 (2). 145-150
11. Jiang M, Wei Q, Pabla N, et al. Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol. 2007 ; 73 (9). 1499-1510 (Pubitemid 46452592)
12. Li F, Chong ZZ, Maiese K. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways. Neurosignals. 2004 ; 13 (6). 265-289 (Pubitemid 40073625)
13. Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron. 1997 ; 77 (2). 176-185 (Pubitemid 27440408)
14. Nemoto T, Yokota N, Keane WF, Rabb H. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int. 2001 ; 59 (1). 246-251 (Pubitemid 32055232)
15. Hodges VM, Rainey S, Lappin TR, Maxwell AP. Pathophysiology of anemia and erythrocytosis. Crit Rev Oncol Hematol. 2007 ; 64 (2). 139-158 (Pubitemid 47488895)
16. Chatterjee PK. Pleiotropic renal actions of erythropoietin. Lancet. 2005 ; 365 (9474). 1890-1892 (Pubitemid 40744968)
17. Patel N, Sharples EJ, Cuzzocrea S, et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int. 2004 ; 66 (3). 983-989 (Pubitemid 39121002)
18. Kasap B, Soylu A, Kuralay F, et al. Protective effect of EPO on oxidative renal injury in rats with cyclosporine nephrotoxicity. Pediatr Nephrol. 2008 ; 23 (11). 1991-1999
19. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 ; 72: 248-254
20. Aust SD, Morehouse LA, Thomas CE. Role of metals in oxygen radical reactions. J Free Radic Biol Med. 1985 ; 1 (1). 3-25 (Pubitemid 16104818)
21. Mercier Y, Gatellier P, Renerre M. Lipid and protein oxidation in vitro, and antioxidant potential in meat from Charolais cows finished on pasture or mixed diet. Meat Sci. 2004 ; 66: 467-473 (Pubitemid 37326349)
22. Vina J, Sastre M, Asensi L, Packer L. Assay of blood glutathione oxidation during physical exercise. Meth Enzymol. 1995 ; 251: 237-243
23. Sian J, Dexter DT, Cohen G, Jenner PG, Marsden CD. Comparison of HPLC and enzymatic recycling assays for the measurement of oxidized glutathione in rat brain. J Pharmacol. 1997 ; 49 (3). 332-335 (Pubitemid 27197025)
24. Clairbone A Catalase Activity. Handbook of Methods for Oxygen Radical Research. Boca Raton, FL: RC Press ; 1985: 283-284.
25. Allcock GH, Hukkanen M, Polak JM, Pollock JS, Pollock DM. Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats. J Am Soc Nephrol. 1999 ; 10 (11). 2283-2289 (Pubitemid 29501460)
26. Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med. 1993 ; 15 (4). 353-363 (Pubitemid 23283552)
27. Kim YH, Mun KC, Lee SS, et al. Oxidative damage in renal transplant patients. Transplant Proc. 2000 ; 32 (7). 1777-1778
28. Dotan Y, Lichtenberg D, Pinchuk I. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res. 2004 ; 43 (3). 200-227 (Pubitemid 38299193)
29. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis. 1997 ; 29 (3). 467-477
30. Shimeda Y, Hirotani Y, Akimoto Y, et al. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull. 2005 ; 28 (9). 1635-1638 (Pubitemid 41324123)
31. Sadzuka Y, Shoji T, Takino Y. Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem Pharmacol. 1992 ; 43 (8). 1872-1875
32. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity.. Kidney Int.. 1998 ; 53 (2). 394-401 (Pubitemid 28097855)
33. Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology. 2004 ; 195 ((2-3)). 221-230 (Pubitemid 38125121)
34. Siren AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA. 2001 ; 98 (7). 4044-4049 (Pubitemid 32249895)
35. Grasso G, Sfacteria A, Cerami A, Brines M. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?. Neuroscientist. 2004 ; 10 (2). 93-98 (Pubitemid 38372870)
36. Hanlon PR, Fu P, Wright GL, Steenbergen C, Arcasoy MO, Murphy E. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling.. FASEB J. ;. 2005 ; 19 (10). 1323-1325 (Pubitemid 41113737)
37. Solaroglu I, Solaroglu A, Kaptanoglu E, et al. Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst. 2003 ; 19 (1). 19-22 (Pubitemid 36798745)
38. Kumral A, Baskin H, Gokmen N, et al. Selective inhibition of nitric oxide in hypoxic-ischemic brain model in newborn rats: is it an explanation for the protective role of erythropoietin?. Biol Neonate. 2004 ; 85 (1). 51-54 (Pubitemid 38437648)
39. Meister A, Anderson ME. Glutathione. Ann Rev Biochem. 1983 ; 52: 711-760 (Pubitemid 13030692)
40. Öztürk E, Demirbilek S, Körolu A, et al. Propofol and erythropoietin antioxidant properties in rat brain injured tissue. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008 ; 32 (1). 81-86
41. Appenroth D, Fröb S, Kersten L, Splinter EK, Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997 ; 71 (11). 677-683 (Pubitemid 27427514)
42. Mora Lde O, Antunes LM, Francescato HD, Bianchi Mde L. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res. 2003 ; 47 (6). 517-522 (Pubitemid 36542930)
43. Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicology. 2005 ; 212 ((2-3)). 116-223
44. Esposito C, Pertile E, Grosjean F. The improvement of ischemia/reperfusion injury by erythropoetin is not mediated through bone marrow cell recruitment in rats. Transplant Proc. 2009 ; 41 (4). 1113-1115